Sentence examples for personalized measures from inspiring English sources

"It's not bad, but it could be a lot better, which is one of the reasons why we're looking at more personalized measures," says neuropsychologist Kate Hoy, who will co-lead the trial.

Personalized measures have been proposed as a method for identifying those aspects of a health condition that impact on QOL.

Personalized measures of QOL have been used in several clinical trials to evaluate the effectiveness of different interventions on overall QOL [ 40- 44].

Smaller, focused studies provide an opportunity to use more costly and exploratory technologies, such as environmental or biologic sensors and toxicogenomics, to develop more personalized measures of environmental exposure.

With respect to prescribing incentive schemes, the interviewees assert the need for personalized measures adapted to each HC and physician that take into account their individual expectations as well as the influence of the measures on the quality and cost of their prescriptions [ 30].

Besides, the respondents did neither mention (potential) distributional issues regarding personalized preventive measures nor did they allude to concerns of data protection, right to know/not to know or potential (genetic) discrimination regarding personalized therapeutic measures.

Using traditional techniques, Anjuna creates hand-made, made to measure, personalized pendants, rings, bracelets, and buckles that turn street art into body ornaments.

Using our automated screening platform, we identified personalized responses by measuring viability, number, and size of organoids after exposure to 240 kinase inhibitors.

We measured personalized stigma and disclosure concerns with the Berger HIV stigma scale [ 40, 41].

In 2011 12, a pragmatic trial on energy healing as rehabilitation after completed hospital treatment for colorectal cancer was conducted in Denmark in order to test guidelines for effectiveness studies measuring personalized treatment goals [ 16– 20].

In the future, personalized therapeutics and prophylactic measures could target gene products or pathways on the basis of information derived from a patient's cellular epigenomic landscape, as defined by open chromatin and the patient's risk variants that localize to this open chromatin.